Clinical trials
Neurologic Disorder clinical trials
Below are recruiting neurologic disorder clinical trials, each written for real people, not researchers. We’re tracking 188 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT02531880RecruitingPhase 1
MRI test of a brain barrier issue in hard-to-treat epilepsy
This early-phase study uses a special MRI approach to look for signs that the “blood-brain barrier” is breaking down in people with drug-resistant epilepsy. It may help researchers understand what is happening in the brain and guide future treatments, though it is primarily a testing/study study.
Bethesda, MarylandAges 18–60 - NCT02629107Recruiting
Sleep and brain scan study with sound cues
This study checks how your brain responds while you sleep using an MRI scanner and gentle sound signals. It may help researchers better understand sleep and brain function.
Bethesda, MarylandAges 18–34 - NCT07446114Recruiting
Brain-computer interface trial for ALS (Canada)
This trial tests a brain-computer interface (BCI) device that may help people with ALS or motor neuron disease regain some control over their environment. It involves implanting the device in a blood vessel in the brain.
Toronto, OntarioAges 18 years+ - NCT07461259Recruiting
Testing a new exoskeleton for walking after spinal cord injury
This trial tests a powered exoskeleton called TWIICE Rise to see if it is safe and possible for people with spinal cord injury to use it for walking. It may help if you have some movement or no movement in your legs but need help standing and walking with crutches.
Nottwil, Canton of LucerneAges 18–70 - NCT07543367Recruiting
Brain implant to restore arm movement in ALS
This study tests a surgically implanted brain-computer interface (BCI)—a device that reads signals directly from your brain to help control a computer cursor or robotic arm. It's designed for people with ALS whose arms are paralyzed and who haven't responded to standard treatments.
Jacksonville, FloridaAges 22 years+ - NCT07560696Recruiting
Web-based therapy for thinking and speech after illness
This study tests whether patients recovering from serious illness in the ICU or stroke ward can use a web-based platform called Cognishine to help rebuild their thinking skills and speech ability. The goal is to see if this online approach works well and is practical for patients receiving support from therapists.
LiverpoolAges 18 years+ - NCT07630311Recruiting
Balance and walking study in multiple sclerosis
This study looks at how multiple sclerosis affects balance, walking patterns, and movement. Researchers will use motion analysis to understand changes, which could help improve treatments.
IoanninaAges 18 years+ - NCT07264166Enrolling by invitation
Gene therapy trial for cerebral palsy and HIE
This trial tests a gene therapy given as a nose spray for people with cerebral palsy or HIE. It aims to see if the treatment is safe and helps improve movement over two years.
Monterrey, Nuevo LeónAges 2–65 - NCT05443321Enrolling by invitation
Health information sharing during hospital transfers
This trial studies whether sharing patients’ health information between hospitals during transfers can improve outcomes. You may be included if you are moved from a specific partner hospital to Brigham and Women’s Hospital and admitted to certain hospital units.
Boston, MassachusettsAges 18 years+ - NCT04095026Enrolling by invitation
Brain recording and stimulation to improve memory
This study tests a brain-recording and brain-stimulation approach to help improve memory. It is offered to adults who are already enrolled in a specific epilepsy surgery program and can safely complete memory-related tasks.
Bethesda, MarylandAges 18–65 - NCT04623593Recruiting
Study of cost and value of neck disc surgery
This study looks at how cost-effective (good value for the money) anterior neck disc surgery is for people with nerve or spinal cord symptoms. If you need this type of operation, it may help doctors better choose treatments and plan healthcare resources.
Maastricht, LimburgAges 18 years+ - NCT05706831Recruiting
Music and gentle brain stimulation after neurological injury
This trial tests whether combining music with gentle electrical brain stimulation can improve symptoms after a neurologic event, such as language and attention problems. It’s meant for adults who are living with effects of stroke and certain levels of reduced awareness.
Bari, BaAges 18 years+ - NCT06797024Recruiting
Study of JY231 injection for tough nerve immune disorders
This trial tests a new injection called JY231 for people with certain hard-to-treat nerve and immune disorders that haven't improved with standard treatments. It aims to see if this experimental therapy can help control the disease when other options have failed.
Wuhan, HubeiAges 18–75 - NCT05943652Recruiting
Study of how functional overlay affects movement disorders
This study looks at movement disorders that are functional (not caused by damage to the nervous system) or non-functional, and how a “functional overlay” may change symptoms. It is observational, meaning it does not test a new treatment, but it may help researchers better understand these differences and improve care.
Graz, StyriaAges 18–18 - NCT06983119Recruiting
Finding early signs of memory loss in Pavia
This study looks for early thinking and memory changes in people 50 and older who haven't been diagnosed with cognitive decline. You'll complete a quick assessment to see if further checkups might help.
Pavia, PaviaAges 18 years+ - NCT07010328Recruiting
AI-guided posture training for Parkinson's disease
This trial tests whether a special training program that uses artificial intelligence can help improve posture in people with Parkinson's disease who have a forward bend or lean to one side. If you have Parkinson's and a noticeable postural problem, this might be a way to try a new approach to rehabilitation.
Pavullo nel Frignano, PaviaAges 18 years+ - NCT00874783Recruiting
Testing nerve-cell growth from donated body cells
This trial uses donated body cells or small hair samples from people with neurological diseases (and healthy donors) to try to grow “nerve-like” cells for research. It may help scientists learn how to better study and treat different neurological conditions.
Jerusalem, IsraelAges 18 years+ - NCT07557706RecruitingPhase 1
Vagus Nerve Stimulation to Improve Heart Function in Parkinson's Disease
This study tests a non-invasive ear-based stimulation technique (taVNS) to help regulate heart function in people with Parkinson's disease. The goal is to see if this gentle stimulation can improve blood pressure and heart rate control.
Birmingham, AlabamaAges 18–80 - NCT04806620Recruiting
Online app study for brain inflammation lifestyle data
This study uses a digital platform (app/website) to collect lifestyle and symptom information to better understand brain inflammation. You may qualify if you have certain conditions like Long COVID, migraines, autoimmune disease, inflammatory gut issues, mood disorders, or if you are a healthy comparison person.
Delafield, WisconsinAges 2 years+ - NCT06627387Recruiting
Balance training with augmented reality for home rehab
This study tests a low-cost balance training platform that uses augmented reality to help people with balance problems from stroke or other brain conditions. It aims to see if the platform is easy and safe to use at home with a training partner.
Barcelona, BarcelonaAges 18 years+ - NCT03495024RecruitingPhase 4
Varenicline for quitting smoking in people with schizophrenia
This trial tests whether varenicline helps people with schizophrenia or schizoaffective disorder stop smoking. It also looks at related nervous-system side effects that can happen with some anti-psychotic medicines.
Philadelphia, PennsylvaniaAges 18–75 - NCT06939166RecruitingEarly Phase 1
Immune cell therapy for relapsed neurological autoimmune diseases
This trial tests a new type of immune cell therapy (CAR T-cells) that targets CD19 and BCMA proteins on B cells. It is for people with certain neurological autoimmune diseases that have come back or not responded to standard treatments. The goal is to see if this therapy can help control the disease.
TianjinAges 18 years+ - NCT07136844Recruiting
Walking and arm movement study for nerve and muscle conditions
This study uses motion analysis to understand walking and arm function in adults with certain neurological or metabolic diseases. The goal is to find patterns that help doctors better manage these conditions.
LiègeAges 18 years+ - NCT07554833Recruiting
Brain Stimulation for Parkinson's Motor and Memory Skills
This study tests whether repeated magnetic stimulation (rTMS) of the brain can help improve movement and thinking problems in people with Parkinson's disease. Researchers will measure how the treatment affects your motor control and cognitive function over the study period.
San Francisco, CaliforniaAges 50–90
Hear when a new Neurologic Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurologic disorder?
- Yes. Clin2 currently lists 188 recruiting neurologic disorder studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurologic disorder trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurologic disorder trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.